Cargando…
COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901182/ https://www.ncbi.nlm.nih.gov/pubmed/35271806 http://dx.doi.org/10.1016/S1473-3099(22)00123-2 |
| _version_ | 1784664303749562368 |
|---|---|
| author | Krantz, Matthew S Phillips, Elizabeth J |
| author_facet | Krantz, Matthew S Phillips, Elizabeth J |
| author_sort | Krantz, Matthew S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8901182 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89011822022-03-08 COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA Krantz, Matthew S Phillips, Elizabeth J Lancet Infect Dis Comment Elsevier Ltd. 2022-06 2022-03-07 /pmc/articles/PMC8901182/ /pubmed/35271806 http://dx.doi.org/10.1016/S1473-3099(22)00123-2 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Krantz, Matthew S Phillips, Elizabeth J COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title | COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title_full | COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title_fullStr | COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title_full_unstemmed | COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title_short | COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA |
| title_sort | covid-19 mrna vaccine safety during the first 6 months of roll-out in the usa |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901182/ https://www.ncbi.nlm.nih.gov/pubmed/35271806 http://dx.doi.org/10.1016/S1473-3099(22)00123-2 |
| work_keys_str_mv | AT krantzmatthews covid19mrnavaccinesafetyduringthefirst6monthsofrolloutintheusa AT phillipselizabethj covid19mrnavaccinesafetyduringthefirst6monthsofrolloutintheusa |